II Calendar No. 20 118th CONGRESS 1st Session S. 142 IN THE SENATE OF THE UNITED STATES January 30, 2023 Ms. Klobuchar (for herself, Mr. Grassley , Mr. Durbin , Mr. Cramer , Mr. Blumenthal , Mr. Kelly , Mr. Van Hollen , Mr. Booker , Mr. Ossoff , Ms. Ernst , and Mr. Welch ) introduced the following bill; which was read twice and referred to the Committee on the Judiciary March 1, 2023 Reported by Mr. Durbin , with an amendment Strike out all after the enacting clause and insert the part printed in italic A BILL To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.